Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,162,512
- Total 13F value
- $1,150,412
- Share change
- +1,763
- SEC-reported price per share
- $0.19
- Number of holders
- 13
- Value change
- -$38,941
- Number of buys
- 5
- Number of sells
- 4
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2022
Institutions
13
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
Chidozie Ugwumba
Comparable rows
14/15
Latest evidence
17 Oct 2022
13F
3/4/5
Lead comparable stake: 177%
1 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 177%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
177%
JOHNSON & JOHNSON
134%
MMCAP International Inc. SPC
43%
ROYCE & ASSOCIATES LP
10%
MILLENNIUM MANAGEMENT LLC
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
177%
|
$957,000
2,813,489 shares
|
— | 30 Sep 2022 |
| JOHNSON & JOHNSON |
13F
Company
|
134%
|
$725,000
2,133,402 shares
|
— | 30 Sep 2022 |
| MMCAP International Inc. SPC |
13F
Company
|
43%
|
$233,000
684,451 shares
|
— | 30 Sep 2022 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
10%
|
$54,000
158,655 shares
|
— | 30 Sep 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
5.5%
|
$30,000
87,757 shares
|
— | 30 Sep 2022 |
| Virtu Financial LLC |
13F
Company
|
4.3%
|
$23,000
68,813 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
6,162,512
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
14
Q4 2022 holders
13
Holder diff
-1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend